Insight Molecular Diagnostics Inc. [IMDX] - Insight Molecular Diagnostics / Chronix Biomedical merger

Insight Molecular Diagnostics Inc. (formerly Oncocyte Corporation) has amended its merger agreement with Chronix Biomedical, Inc., originally dated February 2, 2021, to include modifications regarding Earnout Consideration.

View source filing ↗